Studies have shown that GPX4 and SLC7A11 are central factors in suppressing lipid peroxidation; their high expression significantly enhances the antioxidant capacity of tumor cells, enabling them to evade ferroptosis induced by immunotherapy, chemotherapy, or radiotherapy. This evidence concerns the gene GPX4 and neoplasm.